Mednet Logo
HomeGynecologic OncologyQuestion

Have the presented results of GOG 249 at ASTRO 2017 changed management of early stage uterine papillary serous cancers from chemo +VC/EBRT to pelvic RT only?

1
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Weill Cornell Medical College

UPSC tend to fail with distant mets. Therefore chemotherapy is reasonable.

Per the study results Chemo + VC/EBRT is reasonable.

At times chemo is not feasible/ tolerated so we use EBRT+ Vc.

I have enrolled pts on this study and noted the interesting results.

Register or Sign In to see full answer

Have the presented results of GOG 249 at ASTRO 2017 changed management of early stage uterine papillary serous cancers from chemo +VC/EBRT to pelvic RT only? | Mednet